ZYME
Zymeworks Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -15.4% ·
flujo de acciones -7.5% ·
nuevas posiciones netas -18.2%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -2 | 24.79M | $647.06M | +6 | −8 |
| Q1 2026 | 94 | +3 | 24.89M | $623.10M | +9 | −6 |
| Q4 2025 | 90 | -1 | 25.71M | $677.12M | — | −1 |
| Q3 2025 | 19 | +2 | 15.73M | $268.60M | +2 | −1 |
| Q2 2025 | 15 | +1 | 10.33M | $129.64M | +1 | — |
| Q1 2025 | 11 | 0 | 3.31M | $39.41M | +1 | −1 |
| Q4 2024 | 11 | -2 | 3.00M | $43.95M | — | −2 |
| Q3 2024 | 12 | +2 | 2.16M | $27.11M | +2 | — |
| Q2 2024 | 10 | — | 2.50M | $21.29M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.08M | — | $15.88M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 689.88K | -3.4% | $10.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 689.88K | -3.4% | $10.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 330.13K | +565.8% | $4.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 285.70K | +54.8% | $4.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 219.10K | -9.9% | $3.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 219.10K | -9.9% | $3.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 201.70K | 0.0% | $2.95M | 0.0% | Held | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 63.60K | 0.0% | $931,104 | 0.0% | Held | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 58.36K | +180.5% | $854,361 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 58.36K | +180.5% | $854,361 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 21.58K | +17.6% | $316,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 20.84K | -4.3% | $305,098 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Arrowstreet Capital | $5.12M | era 0.0% |
| Marshall Wace | $2.63M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 209 tenedores, 70.12M acciones, $1.75B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.